000 | 01962 a2200577 4500 | ||
---|---|---|---|
005 | 20250517230338.0 | ||
264 | 0 | _c20181012 | |
008 | 201810s 0 0 eng d | ||
022 | _a1349-7006 | ||
024 | 7 |
_a10.1111/cas.13741 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShimazu, Kazuhiro | |
245 | 0 | 0 |
_aCurcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors. _h[electronic resource] |
260 |
_bCancer science _cOct 2018 |
||
300 |
_a3285-3293 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCurcumin _xanalogs & derivatives |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 |
_aFibronectins _xgenetics |
650 | 0 | 4 | _aGene Knockdown Techniques |
650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aNeoplasms _xblood supply |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
650 | 0 | 4 | _aXenopus laevis |
700 | 1 | _aInoue, Masahiro | |
700 | 1 | _aSugiyama, Shunsuke | |
700 | 1 | _aFukuda, Koji | |
700 | 1 | _aYoshida, Taichi | |
700 | 1 | _aTaguchi, Daiki | |
700 | 1 | _aUehara, Yoshihiko | |
700 | 1 | _aKuriyama, Sei | |
700 | 1 | _aTanaka, Masamitsu | |
700 | 1 | _aMiura, Masatomo | |
700 | 1 | _aNanjyo, Hiroshi | |
700 | 1 | _aIwabuchi, Yoshiharu | |
700 | 1 | _aShibata, Hiroyuki | |
773 | 0 |
_tCancer science _gvol. 109 _gno. 10 _gp. 3285-3293 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/cas.13741 _zAvailable from publisher's website |
999 |
_c28647975 _d28647975 |